Workflow
Qualigen Therapeutics(QLGN)
icon
Search documents
贾跃亭和FF投资的美股上市公司QLGN将11月12日股东大会后更名为 AIxCrypto
Sou Hu Cai Jing· 2025-10-28 14:05
Core Insights - Faraday Future Intelligent Electric Inc. has made a strategic investment in Qualigen Therapeutics Inc., which will be renamed AIxCrypto after the shareholder meeting on November 12, 2025 [1][2] - The investment amounts to over $41 million, with Faraday Future contributing approximately $30 million for a 55% stake, while founder Jia Yueting invests $4 million for a 7% stake [2] - AIxCrypto plans to launch new Web3 and cryptocurrency initiatives, including the public testing of BesTrade DeAI Agent and the release of the EAI RWA Utility token white paper by the end of November [2][3] Investment Details - Faraday Future's investment is led by Jia Yueting and includes participation from Binance Labs, Sequoia Capital, IDG, and Circle [1] - After the investment, Faraday Future and Jia Yueting will collectively hold about 62% of Qualigen Therapeutics [2] Business Strategy - AIxCrypto aims to achieve three key milestones by the end of 2025: 1. Expand the asset management scale of C10 Treasury to $50 million, enhancing its role as a core reserve asset in the Web3 ecosystem [2] 2. Accelerate the global growth of BesTrade DeAI Agent, establishing it as a top AI trading platform [3] 3. Launch a Crypto ecosystem token on leading exchanges, creating a sustainable on-chain value growth system [3]
贾跃亭和FF投资控股上市公司QLGN,11月股东大会后更名AIxCrypto
Sou Hu Cai Jing· 2025-10-28 14:05
Core Insights - Qualigen Therapeutics Inc. (QLGN) will rebrand to AIxCrypto after its shareholder meeting on November 12, 2025, and has set three core objectives for 2025 [1][2] Group 1: Business Strategy - QLGN has initiated a new Web3 and cryptocurrency business plan, with the public beta of BesTrade DeAI Agent set to launch at the end of November [1][2] - The first milestone aims to expand the C10 Treasury's asset management scale to $50 million, enhancing its role as a core reserve asset in the Web3 ecosystem [1] - As of October 17, 2023, QLGN's C10 Treasury has completed a $12 million allocation in cryptocurrency assets [1] Group 2: Product Development - The second milestone focuses on accelerating the global growth of BesTrade DeAI Agent, which is designed to optimize trading paths and returns, establishing itself as a leading AI trading platform [2] - The third milestone involves launching the Crypto ecosystem Token on leading exchanges, which will consist of C10 stablecoin and EAI+Crypto products, aiming to create a sustainable on-chain value growth system [2] Group 3: Investment Details - Faraday Future Intelligent Electric Inc. (FFAI), led by founder Jia Yueting, has made a strategic investment in QLGN, with the total investment expected to exceed $41 million, subject to shareholder approval [3] - FFAI invested approximately $30 million for about 55% ownership in QLGN, while Jia Yueting personally invested around $4 million for about 7% ownership [3] - Post-investment, FFAI and Jia Yueting will collectively hold approximately 62% of QLGN, with FFAI gaining significant board representation [3]
Qualigen Therapeutics to Rebrand as AIxCrypto After Stockholder Meeting on November 12, with Three Core Goals for 2025
Globenewswire· 2025-10-28 03:57
Core Viewpoint - Qualigen Therapeutics Inc. will rebrand as AIxCrypto following its stockholder meeting on November 12, 2025, and is launching new initiatives in the Web3 and crypto asset sectors [1] Group 1: Rebranding and New Initiatives - The company will officially change its name to AIxCrypto and introduce its new business initiatives in the crypto space [1] - AIxCrypto plans to launch the public beta of its BesTrade DeAI Agent by the end of November 2025 and release its EAI RWA Utility Token Whitepaper [2] Group 2: Strategic Goals - AIxCrypto aims to expand the C10 Treasury to $50 million in assets under management (AUM), having completed $12 million in crypto asset allocations as of October 17, 2025 [2] - The company intends to accelerate global growth of the BesTrade DeAI Agent, which will serve as a Meta Exchange optimizing transaction pathways and returns [3] - AIxCrypto plans to launch crypto ecosystem tokens on leading exchanges, supported by a potential C10 stablecoin and EAI + Crypto RWA dual-bridge products [4] Group 3: Company Background - Qualigen Therapeutics, Inc. is a biotechnology company based in Carlsbad, California, focusing on innovative oncology and immunology therapies while expanding into crypto asset and Web3 strategies [5]
Morning Market Movers: CLIK, RNA, DYN, SLGB See Big Swings
RTTNews· 2025-10-27 13:03
Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Click Holdings Limited (CLIK) is up 81% at $11.17 [3] - Avidity Biosciences, Inc. (RNA) is up 43% at $70.72 [3] - Dyne Therapeutics, Inc. (DYN) is up 37% at $23.58 [3] - Zenas BioPharma, Inc. (ZBIO) is up 21% at $29.00 [3] - ProPetro Holding Corp. (PUMP) is up 18% at $7.47 [3] - PepGen Inc. (PEPG) is up 17% at $5.35 [3] - Unusual Machines, Inc. (UMAC) is up 15% at $14.85 [3] - Semler Scientific, Inc. (SMLR) is up 14% at $27.32 [3] - ETHZilla Corporation (ETHZ) is up 13% at $20.51 [3] - Relmada Therapeutics, Inc. (RLMD) is up 13% at $2.38 [3] Premarket Losers - Smart Logistics Global Limited (SLGB) is down 37% at $3.21 [4] - MaxsMaking Inc. (MAMK) is down 22% at $4.08 [4] - Prenetics Global Limited (PRE) is down 14% at $14.40 [4] - United States Antimony Corporation (UAMY) is down 14% at $10.22 [4] - NeurAxis, Inc. (NRXS) is down 12% at $3.01 [4] - Obook Holdings Inc. (OWLS) is down 9% at $11.39 [4] - Qualigen Therapeutics, Inc. (QLGN) is down 9% at $3.30 [4] - Critical Metals Corp. (CRML) is down 8% at $13.70 [4] - Neuphoria Therapeutics Inc. (NEUP) is down 8% at $5.73 [4] - Beam Therapeutics Inc. (BEAM) is down 7% at $25.86 [4]
Morning Market Movers: PMI, QLGN, INBX, MOFG See Big Swings
RTTNews· 2025-10-24 11:56
Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Qualigen Therapeutics, Inc. (QLGN) increased by 69% to $6.00 - Inhibrx Biosciences, Inc. (INBX) rose by 62% to $46.04 - MidWestOne Financial Group, Inc. (MOFG) gained 33% to $37.87 - Neuphoria Therapeutics Inc. (NEUP) up by 31% to $5.32 - Nextracker Inc. (NXT) increased by 13% to $102.44 - Avalon Holdings Corporation (AWX) rose by 11% to $2.98 - Beyond Meat, Inc. (BYND) up by 9% to $3.12 - SLM Corporation (SLM) increased by 8% to $29.00 - Reborn Coffee, Inc. (REBN) rose by 7% to $2.40 - Oriental Culture Holding LTD (OCG) increased by 5% to $3.55 [3] Premarket Losers - Picard Medical, Inc. (PMI) decreased by 70% to $3.89 - Fusemachines Inc. Common stock (FUSE) down by 17% to $3.29 - American Rebel Holdings, Inc. (AREB) fell by 16% to $3.14 - Armata Pharmaceuticals, Inc. (ARMP) down by 13% to $6.16 - Coya Therapeutics, Inc. (COYA) decreased by 13% to $6.01 - Deckers Outdoor Corporation (DECK) down by 12% to $90.00 - Safe & Green Holdings Corp. (SGBX) fell by 12% to $2.58 - Beasley Broadcast Group, Inc. (BBGI) decreased by 8% to $5.55 - Booz Allen Hamilton Holding Corporation (BAH) down by 7% to $92.73 - Brera Holdings PLC (SLMT) decreased by 6% to $10.67 [4]
Qualigen Therapeutics (QLGN) Stock Soars 62% After-Hours On Partnership With BitGo To Build Multi-Asset Crypto Treasury
Benzinga· 2025-10-24 07:12
Core Viewpoint - Qualigen Therapeutics Inc. has partnered with BitGo to enhance its cryptocurrency treasury strategy, leading to a significant surge in its stock price during after-hours trading [1][2]. Group 1: Stock Performance - Qualigen shares increased by over 60% in after-hours trading, building on a 5.37% gain during the regular trading session, closing at $3.530 [2][4]. - Year-to-date, the stock has decreased by 16.15%, but recent trends indicate a stronger price momentum in the short and medium term [4]. Group 2: Partnership Details - The partnership with BitGo allows Qualigen to manage a diversified investment across the top 10 cryptocurrencies, utilizing BitGo's over-the-counter desk [3]. - BitGo will provide custody and liquidity services for Qualigen's digital assets, ensuring they are stored in regulated cold storage with compliance protocols [3]. Group 3: Company Background - Qualigen is majority-owned by Faraday Future Intelligent Electric Inc., indicating a strategic alignment with a company in the electric vehicle sector [3].
Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
Globenewswire· 2025-10-23 20:05
New York, NY, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or “Company”), a publicly-trading technology company majority owned by Faraday Future, today announced a strategic partnership with BitGo, the digital asset infrastructure company, to support its C10 treasury strategy, which accumulate and compound a market-cap-weighted basket of the world’s top 10 crypto assets (excluding stablecoins). Through this partnership, Qualigen will leverage BitGo’s holist ...
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Globenewswire· 2025-10-13 01:00
Core Viewpoint - The recent decline in the crypto market is viewed as a necessary "stress test" rather than a collapse of market fundamentals, providing an opportunity for strategic asset purchases by CXC10 [2][3][5]. Market Analysis - The crypto market experienced a significant deleveraging event, with over $16 billion in positions liquidated, resulting in a loss of nearly $200 billion in total market capitalization [2][3]. - The primary cause of the pullback was excessive leverage and panic selling, exacerbated by geopolitical factors, particularly Trump's tariff threats against China [3][4]. Strategic Response - CXC10 plans to officially launch strategic asset purchases starting next week, capitalizing on the current market conditions to acquire high-quality assets at attractive prices [6][7]. - The company has established necessary infrastructure for asset purchases, including cash settlement and cryptocurrency custody accounts [7]. Investment Framework - The company employs a systematic SMART Investment Framework, focusing on risk management and strategic allocation to navigate market downturns [8][10]. - The investment strategy includes passive defense by tracking the C10 Index and active allocation to top cryptocurrencies based on quantitative analysis [8][9]. Future Plans - CXC10 aims to expand its investment and M&A focus on core blue-chip assets and high-growth projects that have been undervalued during the market correction [12][13]. - The company is also looking to identify startups for strategic mergers and acquisitions to enhance its industry presence [14]. Long-Term Vision - The company maintains a bullish outlook on the long-term crypto market, driven by regulatory compliance, capital inflows, and technological advancements [15][16]. - The mission is to build a Web3 ecosystem that integrates with the real economy, positioning itself to thrive in both bull and bear markets [16].
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Globenewswire· 2025-10-13 01:00
Core Viewpoint - The recent decline in the crypto market is viewed as a necessary "stress test" rather than a collapse of market fundamentals, providing an opportunity for strategic asset purchases by CXC10 [2][3][5]. Market Analysis - The crypto market experienced a significant deleveraging event, with over $16 billion in positions liquidated, resulting in a loss of nearly $200 billion in total market capitalization [2][3]. - The primary cause of the pullback was excessive leverage and panic selling, exacerbated by geopolitical factors, particularly Trump's tariff threats against China [3][4]. Strategic Response - CXC10 plans to officially launch strategic asset purchases starting next week, capitalizing on the current market conditions to acquire high-quality assets at attractive prices [6][7]. - The company has established necessary infrastructure for asset purchases, including cash settlement and cryptocurrency custody accounts [7]. Investment Framework - The company employs a systematic SMART Investment Framework, focusing on risk management and strategic allocation to navigate market downturns [8][10]. - The investment strategy includes passive defense by tracking the C10 Index and active allocation to top cryptocurrencies based on quantitative analysis [8][9]. Future Plans - CXC10 aims to expand its investment and M&A focus on core blue-chip assets and high-growth projects that have been undervalued during the market correction [12][13]. - The company is also looking to identify startups with strong technology for strategic mergers and acquisitions, enhancing its industry presence [14]. Long-Term Vision - The company maintains a bullish outlook on the long-term crypto market, driven by regulatory compliance, capital inflows, and technological advancements [15][16]. - The mission is to build a resilient Web3 ecosystem that integrates with the real economy, positioning itself for growth despite market fluctuations [16].
老币圈人贾跃亭
虎嗅APP· 2025-10-12 13:20
Core Insights - The article discusses how Jia Yueting has successfully navigated the cryptocurrency world, leveraging his past experiences and ambitions in technology and finance to create new narratives and opportunities [4][10]. Group 1: Jia Yueting's Recent Activities - On October 8, Jia Yueting posted a meme related to Binance, which led to a significant increase in the market value of a meme coin associated with it, reaching $30 million within hours [4]. - Following this, he clarified that he had never issued a coin, indicating a strategic approach to managing public perception [5]. - Jia's C10 Treasury reported a floating profit of approximately 7% on its crypto assets, and he made a significant move by acquiring Nasdaq-listed company QLGN for $41 million, planning to pivot it towards cryptocurrency and Web3 [9][34]. Group 2: Historical Context and Evolution - In 2011, Jia Yueting's company LeTV went public, achieving revenues of 598 million yuan, a 151% increase year-on-year, and a net profit of 131 million yuan, an 87% increase [12]. - By 2015, LeTV's revenue reached 13.017 billion yuan, with a market capitalization exceeding 150 billion yuan, marking a peak in Jia's ambitions to create an ecosystem spanning content, hardware, and finance [14]. - In 2016, LeTV established a blockchain lab, aiming to integrate blockchain technology into its existing business model, although financial difficulties soon led to the suspension of these plans [16][19]. Group 3: Challenges and Setbacks - The period from 2016 to 2017 marked a turning point for Jia, as LeTV faced significant financial challenges, leading to his departure to the U.S. amid mounting debts and operational issues [22][24]. - The launch of the "OneChain Box" in 2018, which integrated blockchain features, was seen as a desperate attempt to revive the company but ultimately failed due to regulatory scrutiny [26][28]. Group 4: Current Strategy and Future Outlook - From 2019 to 2024, Jia focused on the automotive sector with Faraday Future, experiencing the complexities of manufacturing while the cryptocurrency market evolved significantly [30][31]. - In 2025, Jia announced the "EAI + Crypto Dual-Flywheel" strategy, aiming to integrate electric vehicles and cryptocurrency management, with C10 Treasury as a key component [33]. - The acquisition of QLGN and the involvement of the SIGN Foundation indicate a strategic shift towards building a compliant and resource-backed narrative in the crypto space [35].